Apitope is a biotech company. It develops antigen-specific immunotherapeutics targeting the immunological basis of autoimmune diseases. The company uses a platform to select and develop peptide-based therapies, known as “apitopes”, which restore the natural balance (immune tolerance) of the immune system.